PathoQuest Information

Charles River Labs has acquired Pathoquest, strengthening its end-to-end biologics testing portfolio with Next Generation Sequencing (NGS). Our GMP-compliant, animal-free NGS assays for viral safety and genetic characterization enable a faster and safer release of biotherapies to patients. Pathoquest, A Charles River Company, is a global CRO specializing in NGS-based Biosafety Quality Control through its iDTECT® assay platform, enabling the rapid and safe release of biotherapies to patients. The company offers validated GMP assays for viral safety testing and genetic characterization of raw materials, cell and gene therapies, monoclonal antibodies, and vaccines. Our testing services are available from facilities located in Paris, France, and Wayne, Pennsylvania. Your GMP Next-Gen Biosafety Partner. Compliant, Faster, Animal-Free.